Clinical Trials Arena July 26, 2024
GlobalData

Medidata’s Clinical Data Studio will be used to streamline trials and improve patient experience.

Eisai has adopted Medidata’s Clinical Data Studio, which aims to transform and modernising the clinical trial efficiency and patient experience.

Launched last month, this AI-driven platform is expected to grant Eisai control over its clinical data, facilitate the execution of scalable and complex trials, and enhance the overall patient experience.

The Clinical Data Studio is a component of the Medidata platform, which centrally manages data from various sources. This integration could be crucial for improving data reliability across the entire trial ecosystem, the company noted.

Medidata global head of sales and executive vice-president Janet Butler said: “Through Clinical Data Studio, Eisai is enabling healthcare stakeholders to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Clinical Trials, Technology, Trends
Ingenious Self-Ask Prompting Technique Boosts Generative AI
How AI is making copyright issues more complicated | Devcom panel
Artificial intelligence method could advance gene mutation prediction in lung cancer
Yair Lotan, MD, on ethical considerations for AI in urology
Promise and Perils of AI in Medicine

Share This Article